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Abstract In order to manage the rise in life expec-
tancy and the concomitant increased occurrence of
age-related diseases, research into ageing has become
a strategic priority. Mouse models are commonly
utilised as they share high homologywith humans and
show many similar signs and diseases of ageing.
However, the time and cost needed to rear aged
cohorts can limit research opportunities. Sharing of
resources can provide an ethically and economically
superior framework to overcome some of these issues
but requires dedicated infrastructure. Shared Ageing
Research Models (ShARM) (www.ShARMUK.org)
is a new, not-for-profit organisation funded by
Wellcome Trust, open to all investigators. It collects,
stores and distributes flash frozen tissues from aged
murine models through its biorepository and provides
a database of live ageing mouse colonies available in
the UK and abroad. It also has an online environment
(MICEspace) for collation and analysis of data from
communal models and discussion boards on subjects
such as the welfare of ageing animals and common
endpoints for intervention studies. Since launching in
July 2012, thanks to the generosity of researchers in
UK and Europe, ShARM has collected more than
2,500 tissues and has in excess of 2,000 mice regis-
tered in live ageing colonies. By providing the
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appropriate support, ShARM has been able to bring
together the knowledge and experience of investiga-
tors in the UK and Europe to maximise research
outputs with little additional cost and minimising
animal use in order to facilitate progress in ageing
research.
Keywords Ageing  Murine models  Tissue
bank
Current challenges faced by researchers using
ageing murine models
Social, medical and technological advances, have
resulted in the extension of life expectancy and an
increase in the number of older individuals (Cracknell
2010). There are many socioeconomic implications of
such a change, including the increased occurrence of
age-related diseases and the associated rise in health
and social care costs (Bloom et al. 2011). In order to
find suitable capacity to address these challenges,
western countries such as the UK have set ageing as a
priority area for their research and development
budget (Ageing: Scientific Aspects 2005). The aim is
to increase research efforts and target disease preven-
tion, early diagnosis, and discovery of new interven-
tions to ensure people stay healthy for longer.
Central to the successful identification of mecha-
nisms of ageing and age-related diseases is the use of
suitable models. Mice are common models of ageing
as they share over 95 % homology in gene sequences
with humans. Moreover, extensive knowledge has
been accumulated on their genetics, which has allowed
the generation of very large resources for basic science
research and for the generation of disease models. For
example, following completion of the mouse genome
sequence, an international consortium was developed,
the International Knock-out Mouse Consortium
(IKMC), to systematically generate mutant embryonic
stem cells for every gene in the mouse genome (20,000
plus genes) (Dolgin 2011). In addition, the Interna-
tional Mouse Phenotyping Consortium (IMPC) was
formed to coordinate the efforts of carrying out high-
throughput phenotyping of each line produced by the
IKMC in order to determine the function of every gene
in the mouse genome (Brown and Moore 2012). The
fact that these mice are being preserved in repositories
and made available to the scientific community
represents a distinct advantage for using mouse
models in ageing research.
However, rearing mice into their old age is
expensive. A wild type mouse shows clear signs of
ageing and degeneration in most tissues only after
18 months (Ferguson et al. 2003; Sayer et al. 2013).
Although costs vary between animal houses, a recent
estimate, which considers a commonly accepted
mortality rate of 50 % for C57BL/6 mice at 25 months
of age (Kunstyr and Leuenberger 1975) set the cost at
*$251/mouse (Conn 2011) and higher for older
animals. The high costs, the difficulty in predicting
demand on a 2–3 year timescale and the financial
implications of unsold animals means only a very
small number of animals are commercially available.
Consequently, rapid access to aged animals is difficult
and ageing research becomes the domain of a small
group of well-funded researchers, with the means to
support rolling colonies of ageing mice.
Researchers with limited financial means or those
newly entering the field of ageing find themselves
trapped between the need to maintain the mice for up
to 30 months to collect pilot data to apply for funding
and the time and high costs that this requires. Most
researchers are discouraged and move their research
effort elsewhere, limiting the pace of research in the
field. In 2010, at the Faculty of Medicine, University
of Sheffield a small questionnaire was launched. Out
of 26 questionnaires returned, five investigators were
already carrying out research into ageing using mice,
however an extra eight were not carrying out such
research at the time but would have done so if animals
were easily available and affordable (Ilaria Bellantu-
ono, personal communication). This suggests there is a
potential to increase the number of researchers inter-
ested in ageing research if the financial and temporal
barriers to acquiring tissues could be overcome. It is
with these barriers in mind that ShARM was estab-
lished to maximise research output.
The benefits and challenges of establishing
a resource for sharing ageing murine models
ShARM is a not-for-profit organisation supporting
investigators already undertaking research into ageing
and aimed at encouraging others not currently under-
taking ageing research to do so, by providing afford-
able and readily available aged murine tissues through
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its biorepository and network of live ageing colonies.
ShARM also offers a collaborative environment
(MICEspace) to create a hub for ageing researchers
using murine models and to assist with collaborations.
The major concept behind ShARM was born from
the observation that research groups able to maintain
ageing colonies are usually interested in a small
number of tissues from each mouse and at the time of
sacrifice, the surplus tissues are discarded. This is
scientifically, ethically and economically ineffective,
as the unwanted tissues could potentially be utilised by
other investigators. The use of surplus tissues not only
benefits investigators in their research efforts but
allows simultaneous analysis of multiple organs in a
single mouse providing scope for a more comprehen-
sive assessment if the data were to be shared.
The concept is simple but it raises the question, why
this has not been done before? A degree of collabo-
rative work had been on-going for years through
personal networking and word of mouth. This was
very effective for people who had been in the field for
a number of years and were well connected but did not
work so effectively for new comers to the field.
Although the need for such a facility had been
discussed for some time in the research community,
so were the perceived barriers to success. When
ShARM investigators took a closer look at those
barriers, it quickly became apparent that there was a
need for logistic support and reassurance when sharing
information and precious resources. The operative
structure of ShARM has been designed to be mindful
of these barriers, reducing the burden on investigators.
An important perceived barrier was related to the
potential variability of the data obtained from the
stored tissues due to the lack of standardization of
conditions of housing, diet, pathogens, genetic traits of
mice reared in different locations, factors known to
affect lifespan (Green 1966). Similarly, investigators
were concerned with regard to the quality and the way
the tissues were harvested and stored and how these
could vary from laboratory to laboratory, introducing
variability in the data generated. To address these
issues all tissues deposited in the biorepository are
collected by the facility coordinator or by selected
assistants, trained according to a standard operating
procedure (SOP). Procedures were established by the
ShARM management board following consultation
with pathologists and researchers with expertise in
each of the tissues harvested, minimising variability
introduced by tissue collection and preservation.
Feedback on the quality of the material provided is
collected to build trust with the users and ensure a high
quality service. As each tissue is barcoded with a
unique number, which allows tracking of the animal
from which the tissue originated and the animal house,
it is possible to identify the source of any problem
arising with the quality of the tissues and promptly
rectify it. To address the issue of standardization
related to the maintenance of ageing mice, large
amounts of information including housing, genetic
trait, diet, pathogens (see Table 1) are collected with
each tissue in a database and passed on to the
investigator.
In this way what was once perceived as a barrier has
been turned into a tremendous opportunity to collect a
vast amount of data which, in time, could be used for
meta-analysis to define the impact of those variables
on the ageing process. Moreover, it has the potential to
allow investigators to produce more robust data by
verifying whether the same finding is reproduced
using tissues from cohorts of animals reared in
different animal houses and all collected according
to a standardised procedure. Last but not least, the
barcoded database offers the opportunity for further
analysis if the investigators are interested to compare
data collected on individual tissues (for example
‘‘omics’’ data) obtained from the same animals in the
different laboratories. This is dependent on the
willingness of investigators to work more collabora-
tively, requiring a shift in cultural attitudes to sharing
and a degree of openness from investigators, who may
feel vulnerable to reveal their data, plans or technol-
ogies too prematurely. For this reason to ensure
investigators feel protected, sensitive data are anon-
ymised and the investigators determine what infor-
mation is released and when.
A further barrier to the establishment of a facility
such as ShARM was the fact that the biorepository
would cover only part of the need of researchers as it is
no substitute for readily available live animals.
However, as rearing animals to old age in large
numbers is economically challenging, this requires
substantial investment and is not compatible with a
self-sustainable facility. For this reason ShARM has
established a database of live ageing colonies held by
investigators in UK and abroad. This is a systemwhich
gives ready access to live mice allowing access to
unused fresh tissues which can be collected according
Biogerontology (2013) 14:789–794 791
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to the desired specification. Moreover, it allows
greater flexibility in terms of planning for animals to
be aged. As research priorities can often change over
the time needed to age the mice, ShARM offers
researchers the opportunity to communicate with each
other and make available any unwanted animals to
other researchers, in turn creating greater chances of
finding spare aged animals to use at relatively short
notice.
What is ShARM today
ShARM is open to all investigators from academic
research institutes and industry. ShARM was initiated
by a collaboration between two of the Universities
(Sheffield and Newcastle) at the MRC—Arthritis
Research UK Centre for Integrated Research into
Musculoskeletal Ageing (CIMA) and MRC Harwell.
It is supported by Wellcome Trust but has pledged to
become self-sustainable within 5 years. The facility is
administered in a transparent way through a manage-
ment board, which includes the investigators holding
theWellcome Trust grant and four users, who serve on
the board for 2 years. Any user can apply to become a
member of the management board. Balance sheets and
minutes of the meetings are available in the members
area of the website.
The biorepository
This is the tissue bank for the acquisition, storage and
provision of flash frozen tissues from a range of aged
murine models of different strains, ages and sexes. At
the time of harvest, unwanted tissues are donated by
investigators. Assistance is available for tissue col-
lection or a financial incentive may be available upon
request to cover some of the additional costs involved
in tissue harvest. Investigators with aged colonies are
encouraged to consider depositing samples at the time
of harvest. To avoid variability in the collection and
ensure quality of the material, all tissues harvested are
collected directly by the ShARM coordinator or
nominated assistant according to a strict Standard
Operating Procedure. At present, the biorepository
holds 2,500 tissues from more than 250 mice aged
from 1 to 33 months old. Examples of the tissues
available for purchase are listed in Table 2. To ensure
high tissue quality, the brain and intestine are frozen in
liquid nitrogen within 3 mins from the time of
sacrifice and all other tissues within 10 mins. Samples
are stored at -80 C in a well-established large scale
biorepository which includes forty three freezers with
a total capacity of more than 1.5 million samples. The
facility is highly secure and monitored 24/7 by an
outside control roomwhich is immediately notified if a
problem, such as an increase in temperature is
detected. At present, it costs £35 for aged tissue and
£30 for young controls, excluding shipping costs.
These prices are set only to recover costs and may
change depending on the costs incurred for the harvest
of the tissues.
Tissue samples are accompanied by a dossier of
information regarding the mouse’s pedigree, rearing
and method of sacrifice (Table 1). Samples and their
data are managed using a highly secure database with
standards compliant for the Human Tissue Act regu-
lations for biobanking. The database recognises each
individual tissue with a barcode, so samples are easily
retrieved without repeated exposure to warmer
Table 1 Information collected with tissues deposited in the biorepository
Contributor info Mouse info Cage details Nutrition Sacrifice
Anonymous
institute ID
Mouse strain
DOB
Gender
Breeder status
Source
Provision of young, control
models
Procedure/treatment of
animal
Type
Size
Animals per cage
Air changes per hour
Frequency of cage change
Type of environmental
enrichment used
Type of chow
Chow composition
Chow processing prior
to use
Feeding regime
Watering regime
Water type/treatment
Water delivery system
Date of sacrifice
Time of sacrifice
Method used
Gross anatomical
observations
Tissue treatment
history
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temperatures and it provides a secure mechanism to
connect each sample with the respective data and other
tissues derived from the same animal.
On request of the funding body and the commercial
suppliers of mice, a material transfer agreement
(MTA) is signed every time a tissue is donated or
purchased. MTAs are designed to agree the terms of
use of the tissues including the division of any
intellectual property arising from their use. The
MTA establishes that the tissues must be used for in-
house research only and cannot be passed on to a third
party without the implementation of a subsequent
MTA.
Live ageing colonies
The live ageing colonies comprises an international
database of current cohorts of ageing mice from which
tissues will be available at the time of harvest. This
service provides greater flexibility for acquiring
tissues. This may be ideal for investigators who
require a specific tissue, not available in the biorepos-
itory or require a tissue collected using a specific
protocol. Full details of the colonies available can be
downloaded from www.ShARMUK.org following
registration.
An investigator, interested in using tissues from a
colony, will send a request to ShARM’s administrator
who will contact the colony owner. Once both parties
are agreed, the contact details of both parties will be
exchanged and the practicalities of collection can be
coordinated. Payment and MTAs are agreed directly
between parties. At present the database holds over
2,000 ageing animals.
MICEspace
MICEspace is an online collaborative environment
designed to foster interactions, exchange ideas and
knowledge, and provide help and support through
forums or private messaging. Opportunities also exist
to share best practice especially for carers of the aged
mice in order to help improve the welfare and
determine humane endpoints.
The facility also offers the opportunity to compre-
hensively exchange, compare and collate data on a
scale unprecedented in the ageing community. Inves-
tigators using tissues from communal mice are
encouraged to share data which can be analysed to
Table 2 Flash frozen tissues
available from the ShARM
biorepository
Strains Age range Tissues available
C57Bl/6J
C57Bl/6JBabr
C57Bl/6N
C57Bl/Icrfat
1–4 and 13–33 months Bladder
Bone (femur, tibia, vertebra)
Brain
Brown adipose tissue
Intestine (duodenum, jejunum, ileum,
cecum, colon)
Heart
Kidney
Liver (median, left, right
and caudate lobes)
Lung
Mammary fat pad
Muscle
Pancreas
Prostate
Skin
Spleen
Thymus
Thyroid
White adipose tissue
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investigate the effect of ageing simultaneously in
different tissues.
Conclusion
ShARM has been designed to provide maximum
support to its users and minimise barriers to sharing
but its success lies with its users and their spirit of
collaboration. Since launching in July 2012, the
facility has received surprising enthusiasm with over
50 members registered from six countries and at
different stages of their careers. The current economic
climate together with increasing demands for sharing
by funders and journals may encourage the research
community to share, so facilities such as ShARM are
timely. Investigators wishing to get involved can visit
www.ShARMUK.org and register to become a
member. It is a free, quick and easy process which
provides access to all the information and means to
acquire tissue. Opportunities are also available for
members who wish to get involved in the governance
of the facility.
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